Strata Oncology Company

Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Technology: Biotechnology, Genetics, Health Care, Health Diagnostics, Medical Device
Industry: Clinical Development
Headquarters: Ann Arbor, Michigan, United States
Founded Date: 2016-01-01
Employees Number: 51-100
Funding Status: Late Stage Venture
Investors Number: 13
Total Funding: 128000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-07-28
Last Funding Type: Series C

Visit Website
partner@strataoncology.com
https://twitter.com/StrataOncology
Register and Claim Ownership